Amgen deal expands manufacturing capabilities in Turkey; FDA offers help to small operators;

> Amgen ($AMGN) has completed the acquisition of Turkey-based Mustafa Nevzat Pharmaceuticals, which will expand its reach in an area of fast growth. Story

> Biogen Idec ($BIIB) expects the market for injectable MS drugs to shrink as patients choose more convenient delivery forms. Article

> The FDA is offering draft guidance for small companies on how to comply with rules for labeling pharmaceuticals with toll-free numbers for reporting adverse affects. Release

> Nigeria's second-largest drugmaker, May & Baker of Nigeria, reports that it is about to start vaccine production as part of a joint venture with the government. Story

And Finally... Having integrated the acquisition of Pharmacontrol Electronic, Mettler Toledo is taking what it calls its ramped-up track-and-trace product to the U.S. Story

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.